US$ 29.70
fda approved glp-1 drugs list of and pending medications Market Overview: GLP-1 Agonists and
Description
[DOI] [PMC free article] [PubMed] 55.Frias JP, Bonora E, Nevarez Ruiz L, Li YG, Yu Z, Milicevic Z, et al

In the SELECT trial, participants taking semaglutide 2.4 mg weekly lost an average of 10.2% of body weight over four yearsand that loss was sustained

GLP-1s are known to have positive cardiovascular effects, and better control of blood glucose levels through GLP-1 treatment has been shown to limit small blood vessel damage that can lead to health complications such as diabetic retinopathy
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
doi: 10.1016/S0140-6736(24)00351-9
